Xuchen Wang

机构：Zhengzhou University, Zhengzhou Children's Hospital · ORCID：0000-0002-3665-7069

发表论文 20 篇 · 总被引 594 次 · h-index 8

代表论文

• High-fidelity Cas13 variants for targeted RNA degradation with minimal collateral effects (2022 · Nature Biotechnology · 被引 233)
• Programmable A-to-Y base editing by fusing an adenine base editor with an N-methylpurine DNA glycosylase (2023 · Nature Biotechnology · 被引 200)
• Development of deaminase-free T-to-S base editor and C-to-G base editor by engineered human uracil DNA glycosylase (2024 · Nature Communications · 被引 52)
• Supramolecular fluorogenic peptide sensor array based on graphene oxide for the differential sensing of ebola virus (2020 · Chemical Communications · 被引 30)
• Intratumoral delivery of a novel oncolytic adenovirus encoding human antibody against PD-1 elicits enhanced antitumor efficacy (2022 · Molecular Therapy — Oncolytics · 被引 16)
• Adenovirus delivery of encoded monoclonal antibody protects against different types of influenza virus infection (2020 · npj Vaccines · 被引 14)